Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Gutclaus Zn
- Development stage
- Unknown
- Lead developer
- Amspro Lifesciences
- Modality
- Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Administration
- Oral
01
Overview
Gutclaus Zn is an over-the-counter (OTC) probiotic and mineral combination supplement developed by Amspro Lifesciences. Formulated as a liquid oral suspension, it contains spore-forming *Bacillus clausii* probiotic bacteria (available in 2 Billion or 4 Billion CFU strengths) combined with Zinc (2 mg, 3 mg, or 5 mg per 5 ml). *Bacillus clausii* is a highly stable, spore-forming bacterium capable of surviving gastric acid to reach the intestines, where it helps restore healthy gut microbiota. Zinc provides complementary nutritional support to enhance immune function and maintain mucosal barrier integrity. Gutclaus Zn is primarily indicated for the management of acute and chronic diarrhea, antibiotic-associated diarrhea, traveler's diarrhea, rotavirus diarrhea, and pediatric diarrhea.
- Brand names
- Gutclaus Zn
- Other names
- Bacillus clausii + Zinc
Beyond the preview
Go deeper on Gutclaus Zn.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Gutclaus Zn.